Transmyocardial revascularization

Cummings J P
Record ID 31998008686
Authors' objectives:

This technology report was undertaken to provide a critical appraisal of the available medical evidence pertaining to the safety, efficacy and utility of transmyocardial revascularization (TMR) technology, as well as to provide recommendations to aid in formulating hospital policy and making clinical decisions.

Authors' recomendations: Preliminary data suggest that TMR has an acceptable survival rate, effectively relieves angina, increases exercise capacity, and improves the quality of life for no-option patients. However, data showing improved myocardial perfusion, cardiac function, or prognosis are inconclusive. Also, the mechanism by which TMR acts to relieve angina is still unknown.
Authors' methods: Systematic review
Project Status: Completed
URL for project:
Year Published: 1998
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Coronary Disease
  • Laser Therapy
  • Myocardial Revascularization
Organisation Name: University HealthSystem Consortium
Contact Address: University HealthSystem Consortium, 2001 Spring Rd., Suite 700, Oak Brook, IL 60523 USA. Tel: 630-954-1700, Fax: 630/954-4730
Contact Name:
Contact Email:
Copyright: University HealthSystem Consortium
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.